Question 2 of 6
A.
Cardio-renal protection and cardiovascular risk management.
B.
Weight management.
C.
Medication for glycemic management.
D.
All Above.
1. Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):31-8
2. The EMPA-KIDNEY Collaborative Group. N Engl J Med 2023;388:117
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int Suppl 2013;3:1
4. Perkovic V et al. N Engl J Med 2019;380:2295
5. Wheeler DC et al. Nephrol Dial Transplant 2020;35:1700
6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int Suppl 2024;105: 117-314